Clinical trials recruiting in Huixquilucan, Mexico

Phase breakdown

Conditions recruiting in Huixquilucan, Mexico

Recruiting trials in Huixquilucan, Mexico

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
  NCT07392190 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
  NCT07058077 · Phase: Phase 2, Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female)
• A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
  NCT07192952 · Phase: Phase 3 · Ages: Up to 18 Years · Sex: All (male and female)
• A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
  NCT07188805 · Phase: Phase 3 · Ages: 6 Months to 17 Years · Sex: All (male and female)
• Lactobacillus Acidophilus and Inulin for Cognitive Impairment in Obesity
  NCT07810517 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 40 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Huixquilucan, Mexico?

5 recruiting trials have at least one study site in Huixquilucan, Mexico.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.